News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AltheaDx Laboratory Receives Accreditation From College of American Pathologists


7/21/2014 1:32:09 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO, July 21, 2014 (GLOBE NEWSWIRE) -- AltheaDx, a molecular diagnostics company pioneering the field of pharmacogenetics, today announced that the College of American Pathologists (CAP) has awarded accreditation to the AltheaDx laboratory in San Diego, California based on results of a recent on-site inspection. This accreditation is awarded to facilities that meet the highest standards of quality in laboratory services. With this recognition, the AltheaDx laboratory joins the prestigious ranks of some of the most prominent clinical laboratories in the world.

"We are extremely proud to receive CAP accreditation," stated Greg Hamilton, AltheaDx's Chief Executive Officer. "This national recognition reaffirms our commitment to providing the highest quality laboratory services and reliable testing results to our clients, and is reflective of our focus on helping healthcare providers take better care of patients suffering from serious medical conditions."

The U.S. federal government recognizes the CAP Laboratory Accreditation Program, which began in the early 1960s, as being equal-to or more-stringent-than the government's own inspection program. During the CAP accreditation process inspectors examine the laboratory's quality system, quality control program and quality records for the preceding two years. CAP inspectors also examine laboratory staff qualifications, validation of tests and systems, equipment, facilities, safety program and record, and overall management.

About AltheaDx

AltheaDx is a molecular diagnostics company which focuses on assisting physicians, managed care organizations, pharmaceutical companies and other healthcare entities in their efforts to make the best possible therapeutic decisions for patients through the implementation of personalized medicine. AltheaDx's IDgenetix pharmacogenetic, or PGx, product testing portfolio addresses some of the most prevalent clinical conditions in the United States, including cardiovascular disease, neuropsychiatric disorders and pain. AltheaDx is a CAP-Accredited, CLIA-Certified laboratory located in San Diego, CA. For more information, visit www.altheadx.com.

Forward Looking Statements

This press release may contain forward-looking statements regarding the business strategy of AltheaDx. These statements relate to future events and involve known and unknown risks, uncertainties and other factors that could cause actual levels of activity or performance to differ materially from those expressed or implied by these forward looking statements. These statements reflect the views of AltheaDx as of the date of this press release with respect to future events and, except as required by law, it undertakes no obligation to update or revise publicly any forward looking statements, whether as a result of new information, future events or otherwise after the date of this press release.

About the College of American Pathologists

The College of American Pathologists (CAP), celebrating 50 years as the gold standard in laboratory accreditation, is a medical society that serves more than 18,000 physician members and the global laboratory community. It is the world's largest association composed exclusively of board-certified pathologists and is the worldwide leader in laboratory quality assurance. The College advocates accountable, high-quality, and cost-effective patient care. More information about the CAP can be found at www.cap.org.

CONTACT: Kristen Nungesser ICR, Inc. (646) 277-1261 kristen.nungesser@icrinc.com

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES